netFormulary NHS
Bedfordshire and Luton Joint Formulary
Bedford Hospital NHS Trust
Bedfordshire CCG
Luton & Dunstable University Hospital NHS Foundation Trust
Luton CCG
 Search
 Formulary Chapter 1: Gastro-intestinal system - Full Chapter
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

 Details...
01.05.03  Expand sub section  Drugs affecting the immune response
01.05.03  Expand sub section  Cytokine inhibitors
Adalimumab (Humira)
(Gastroenterology)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine

Not for new patients - use Imraldi.

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

40mg Pre-filled Pen
40mg Pre-filled Syringe
40mg/0.8mL Injection

Restricted to prescribing by NICE criteria or by approved individual funding request (IFR) ONLY.
 

 
Link  NICE TA187: Crohn's disease - infliximab (review) and adalimumab (review of TA40)
Link  NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
Link  NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa
   
Adalimumab (Imraldi)
(Gastroenterology)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine

Biosimilar brand for all new patients. FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

40mg/0.8mL Pre-filled Pen
40mg/0.8mL Pre-filled Syringe
Restricted to prescribing by NICE criteria or by approved individual funding request (IFR) ONLY.

Refer to NICE TA's above
 

 
   
Golimumab
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
FOR ALL PRESCRIBING Blueteq or High cost drug form required see link from Formulary homepage.

Restricted to prescribing by NICE criteria or by approved individual funding request (IFR) ONLY.

50mg Pre-filled Pen
50mg Pre-filled Syringe
 
Link  NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
   
Infliximab (Remicade)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
FOR ALL PRESCRIBING Blueteq or High cost drug form required see link from Formulary homepage.

Restricted to prescribing by NICE criteria or by approved individual funding request (IFR) ONLY.

 
Link  JPC: Infliximab for the management of diarrhoea or colitis associated with Immune Checkpoint Inhibitor (ICPI) therapy
Link  NICE TA140: Ulcerative colitis (subacute manifestations) Infliximab
Link  NICE TA163: Ulcerative colitis (acute manifestations) Infliximab
Link  NICE TA187: Crohn's disease - infliximab (review) and adalimumab (review of TA40)
Link  NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
   
Infliximab (Remsima)
View adult BNF View SPC online
Restricted Drug Restricted
Red
High Cost Medicine
FOR ALL PRESCRIBING Blueteq or High cost drug form required see link from Formulary homepage.

Restricted to prescribing by NICE criteria or by approved individual funding request (IFR) ONLY.

 
Link  JPC: Infliximab for the management of diarrhoea or colitis associated with Immune Checkpoint Inhibitor (ICPI) therapy (December 2019)
Link  NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
   
01.05.03  Expand sub section  Vedolizumab
 ....
 Non Formulary Items
Infliximab  (Inflectra)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

RED - Hospital only to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment  

Amber

Amber medicines are considered suitable for GP prescribing following specialist initiation.  

Green

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations   

Amber SCG

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.   

Black

A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.   

netFormulary